 |
NanoDTPA(tm) |
|---|---|
| Trade Name | |
| Orphan Indication | Known or suspected cases of internal contamination with plutonium, americium, or curium |
| USA Market Approval | USA |
| USA Designation Date | 2011-06-17 00:00:00 |
| Sponsor | Nanotherapeutics, Inc.;13859 Progress Blvd;Alachua, Florida, 32615 |
